Medizinportal Arztsuche Apothekensuche KliniksucheHealth Provider Directory - Health in Germany - english-language-version
Home DocSearch ClinicSearch HealthSites


Anadys Pharmaceuticals Announces Exclusive Collaboration With Novartis to Develop and Commercialize ANA975 and Additional TLR7 - Based Therapeutics for Hepatitis C and Hepatitis B
San Diego, California ( PRN/ots ) - - Total Partnership Valued at Up to USD$570 Million in Upfront and Potential Milestone Payments Anadys Pharmaceuticals, Inc. ( Nasdaq: ANDS ) announced today that it has entered into an exclusive global license and co - development agreement with Novartis to (...)
Pieris reports preclinical development progress of its next generation VEGF antagonist / PRS - 050 program on track to commence clinical trials as planned
Freising - Weihenstephan, Germany ( na Originaltextservice ) - Pieris AG, the biopharmaceutical company developing Anticalins as a novel class of targeted human protein therapeutics, today reported continued progress in development of its lead therapeutic program for the clinic. Under its manufacturing agreement with Wacker (...)
Pieris Appoints a New CEO / Appointment will bring substantial deal - making expertise to the company
Freising - Weihenstephan, Germany ( na Originaltextservice ) - Pieris AG today announced the appointment of Stephen S. Yoder as CEO with immediate effect. Mr. Yoder takes over the position from interim CEO and co - founder Claus Schalper, who will remain CFO. Mr. Yoder joins (...)
Abbott Launches Next - Generation StarClose( R ) SE Vascular Closure System
Abbott Park, Illinois ( PRN/ots ) - - New Device Designed to Provide Fast, Safe and Secure Vessel Closure Following Catheterization Procedures Abbott today announced the launch of the StarClose( R ) SE Vascular Closure System, a next - generation vessel closure device engineered to enable fast, safe (...)
Women With Breast Cancer Do Not Get Potentially Life - Saving Information, Newly Published Survey Results Reveal
Milan, Italy and Stockholm, Sweden ( PRN/ots ) - - Three - Quarters of Women Were Not Told Their Risk of Recurrence - Older, Less Educated Women or Those Without Internet Access are Particularly Uninvolved and Uninformed - New Tools, Better Communication Between Health Care Professionals and (...)
New Website Looks at the Science Behind Stroke
Macclesfield, England ( PRN/ots ) - - Aims to Increase Understanding of Acute Ischemic Stroke and the Potential Role of Neuroprotection - For Medical Media Only A new resource for the international medical community was launched in September 2006 by AstraZeneca, This educational site (...)
Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
Lyon, France ( PRN/ots ) - - Novel Vaccine Approach Tested in the UK Against One of the Most Common Causes of Hospital - Acquired Infection in Europe and North America Sanofi Pasteur, the vaccines division of sanofi - aventis Group ( EURONEXT : SAN et NYSE : SNY ), announced (...)
Janssen - Cilag International NV Submits Marketing Authorization Application in Europe for New Antibiotic
Beerse, Belgium ( PRN/ots ) - Janssen - Cilag International NV has submitted a Marketing Authorization Application ( MAA ) to the European Medicines Agency ( EMEA ) for ceftobiprole, an investigational antibiotic for the treatment of complicated skin and soft tissue infections ( cSSTI ) including diabetic foot infections. Ceftobiprole, the first (...)
Isotechnika's Phase III Psoriasis Spirit Trial Achieves Safety and Efficacy Endpoints
Edmonton, Canada, November 7 ( PRN/ots ) - Isotechnika Inc. ( TSX: ISA ) announced today the unaudited 24 week data for the Company's Canadian Phase III psoriasis trial for its lead immunosuppressive drug, ISA247. A summary of the results is as follows: - All primary and (...)
Sanofi pasteur to License Single Dose Japanese Encephalitis Vaccine From Acambis
Lyon, France ( PRN/ots ) - - New Vaccine Will Help Improve Public Health in Japanese Encephalitis Endemic Countries Sanofi pasteur, the vaccines business of the sanofi - aventis Group, announced today it has entered into an agreement with Acambis plc to license a single dose (...)
FDA Allows Long Term Use of ISA247 in Isotechnika Phase 2b Kidney Transplant Trial
Edmonton, Canada ( PRN/ots ) - Isotechnika today announced that the Company has received permission from the Food and Drug Administration of the United States ( FDA ) for the long term use of ISA247 in patients currently participating in the Company's Phase 2b kidney transplant ( PROMISE ) trial. (...)
New Data Offers Hope to Patients With Bipolar Disorder and Schizophrenia
Paris ( PRN/ots ) - - For Healthcare and Medical Reporters ( non - US ) Bipolar disorder is the sixth largest cause of disability worldwide in people aged 15 - 44 years[1] and is commonly mistaken for other diseases such as acute depression. Consequently, people may suffer (...)
Men, Partners and Patients in Europe United Against Prostate Cancer
Barcelona, Spain ( PRN/ots ) - - New Survey Highlights Need for Education Resources, Critical Role of Physician in Patient Communication and Importance of Maintaining Normal Lifestyle During Treatment Findings from a survey of European prostate cancer patients, presented at the 2nd European Multidisciplinary Meeting (...)
Newest HIV Drugs Should be Used With FUZEON( R )
Rio De Janeiro, Brazil ( PRN/ots ) - - Giving Patients Facing HIV Resistance Their Best Chance to Achieve Undetectable Viral Loads Data presented at IAS build a compelling case for FUZEON ( enfuvirtide, formerly known as T - 20 ) to be combined with the newest drugs (...)
Ground - Breaking Combination of All - Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
BASEL, Switzerland, BRISBANE, California and PRINCETON, New Jersey, April 25 ( PRN/ots ) - - - Combination of R7227, Protease Inhibitor, and R7128, Nucleoside Polymerase Inhibitor, Shows Significant Potency in Reducing Viral Load in Patients With Hepatitis C Roche ( SWX: RO, ROG; OTCQX: RHHBY ), InterMune, Inc. (...)
'Improvement through Movement' educational programme launched for people with osteoporosis / Pan - European osteoporosis patients encouraged to dance their way to stronger bones
Munich, Germany ( na Originaltextservice ) - An educational programme available on DVD is launched today, on World Osteoporosis Day, bringing together the glamorous world of ballroom dance with the serious nature of disease management. Sponsored by DAIICHI SANKYO EUROPE and endorsed by the (...)
Movetis Files RESOLOR( R ) With EMEA for the Indication of Chronic Constipation
Turnhout, Belgium ( PRN/ots ) - Movetis today announced that the European Medicines Agency ( EMeA ) has accepted the Marketing Authorization Application ( MAA ) submission for RESOLOR( R ) ( prucalopride ) as a treatment for chronic constipation in adults in whom laxatives fail to provide adequate relief. RESOLOR is a new (...)
90 Prozent of Cancer Patients Completely Unaware of New Breakthrough Cancer Therapy Which Medical Experts Believe Could Reduce Cancer to a Chronic Disease
Zurich, Suisse ( PRN/ots ) - - Knowledge Gap of Concern to Both Physicians and Patient Groups Nine out of ten patients battling cancer in Europe have never heard of a major breakthrough in cancer treatment, known as anti - angiogenesis, according to a new (...)
PharmaMar Confirms Intention to Submit MAA to EMEA for YONDELIS( R ) in Soft Tissue Sarcoma
Madrid ( PRN/ots ) - - IDMC Recommends Adoption of 24hr Dosing in Pivotal Trial PharmaMar today announces that the independent data monitoring committee ( IDMC ) for the pivotal trial of YONDELIS( R ) in Soft Tissue Sarcoma ( STS ) has reviewed data from a pre - planned interim (...)
Supporting innovative pain research / EFIC - Grunenthal Grant 2009 awarded to five young scientists
Aachen ( na Originaltextservice ) - The European Federation of Chapters of the International Association for the Study of pain ( EFIC ) and the pharmaceutical company Grunenthal awarded the EFIC - Grunenthal Grant to five young European scientists. The grant will provide financial support for their (...)
US Patent Office Rejects 95 Prozent of Verathon Claims in Patent Case With Aircraft Medical
Edinburgh, Scotland ( PRN/ots ) - On March 23, 2009 the United States Patent and Trademark Office ( "USPTO" ) issued a Non - Final Action Closing Prosecution in the ongoing re - examination of Verathon, Inc.'s United States Patent Number 6,543,447. Aircraft Medical, Ltd. filed the request for the (...)
European Commission Approves Use of Anti - Epileptic Keppra( R ) as Adjunctive Therapy in Children Four Years of Age and Older With Partial - Onset Seizures
Brussels, Belgium ( PRN/ots ) - Today UCB announced that the European Commission has approved the use of Keppra( R ) ( levetiracetam ) in the European Union, as adjunctive therapy in the treatment of partial - onset seizures, with or without secondary generalisation, in children from four to sixteen years (...)
Isotechnika Reports Final Results of the PROMISE Trial
Edmonton, Canada ( PRN/ots ) - Isotechnika Inc. ( TSX:ISA ) today announced positive results from the Phase 2b PROMISE trial which evaluated the Company's lead drug, voclosporin , in de novo kidney transplant patients. This trial was designed to determine the most appropriate dosing strategy for (...)
Orion Pharma and Novartis Launch First Parkinson's Disease Study to Explore Potential of Delaying Motor Complications With Stalevo( R )
Espoo, Finland ( PRN/ots ) - - Parkinson's Patients who Require the Start of Levodopa Therapy may be Eligible to Participate in This Study Orion Pharma and Novartis announced that they are launching STRIDE - PD ( STalevo Reduction In Dyskinesia Evaluation ). This major study in Parkinson's (...)
AMP's SIVAC Initiative Supports Mozambique to Set Up its National Immunization Technical Advisory Group ( NITAG )
Paris ( PRN/ots ) - The inaugural meeting of Mozambique's Committee of Experts on Immunization ( Comité de Peritos para a Imunização, CoPI ) was held in Maputo on January 7, 2011. The CoPI is the second National Immunization Technical Advisory Group ( NITAG ) in a sub - Saharan (...)
Agendia Supports Genentech's Citizen's Petition Urging FDA to Hold In - Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards
Huntington Beach, California, and Amsterdam ( PRN/ots ) - Agendia, a world leader in molecular cancer diagnostics, today announced its strong support of Genentech's Citizen's Petition. Filed on December 5, 2008, Docket No. FDA - 2008 - P - 0638 - 0001/CP petitions that all in vitro diagnostic (...)
Pieris AG enters into Anticalin Collaboration with Allergan, Inc.
Freising - Weihenstephan, Germany ( na Originaltextservice ) - Pieris AG today announced that they have entered into a collaboration agreement with Allergan, Inc. ( NYSE: AGN ) that combines Pieris' proprietary Anticalin technology with Allergan's expertise in drug delivery and ophthalmic drug development with a goal (...)
Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology
Biocitech Park, Romainville, France ( PRN/ots ) - Cellectis SA ( NYSE: ALCLS ), a world leader in rational genome engineering, has announced today that it filed a patent infringement lawsuit against Precision BioSciences, Inc. in the United States District Court for the Eastern District of North (...)
ALK - Abelló, the Makers of GRAZAX( R ), Present Successful Phase III Clinical Study Results with Children
Horsholm, Denmark ( PRN/ots ) - - Results Show Highly Significant Effect on Rhinoconjunctivitis ( Hay Fever ) and Asthma Symptoms in Children from age 5 to 16 Years - old ALK - Abelló yesterday presented successful Phase III clinical study results with GRAZAX( R ) in children at the American (...)
Organon and Philips Team up to Study Drug Effects at the Molecular Level
Oss and Eindhoven, The Netherlands ( PRN/ots ) - N.V. Organon, the human health care business unit of Akzo Nobel, and Royal Philips Electronics announced today that they will join forces in the development of new drugs and therapies for mental disorders and cancer. With the (...)
Pieris enters into a collaborative research and option agreement with GE Healthcare
Freising - Weihenstephan, Germany ( na Originaltextservice ) - Pieris Proteolab AG and GE Healthcare today announced that they have entered into a research collaboration for the discovery of novel targeted in vivo diagnostic and medical imaging compounds, a technology that could enable earlier detection and diagnosis of major (...)
Lymphoma Experts Herald 10 Years of the "Magic Bullet"
Lugano, Switzerland ( PRN/ots ) - - Award and Lecture Mark Anniversary of Monoclonal Antibodies Today, physicians and patient group representatives from around the world celebrated the presentation of the San Salvatore Foundation award for outstanding achievement in the field of malignant lymphoma and the (...)
Intellectual Property Protection for GMAT Upheld in China Court Ruling
Mclean, Virginia ( PRN/ots ) - In a precedent - setting decision released on December 27, 2004, the Beijing High Court ( the highest court in Beijing, China ) has ruled in favor of the Graduate Management Admission Council( R ) in the Council's copyright infringement suit against the Beijing New (...)
Leading HIV Experts Convene to Tackle the Challenge of Late Presentation in Europe
London ( PRN/ots ) - - Between 15 to 38 percent of HIV - infected persons in Europe do not present for screening and treatment until late in infection.( 1 ) Late presentation has been show to result in increased morbidity( 1 ) and decreasing quality of life.( 2,3 ) Almost three (...)

back... 1 2 3 4 5 6 7 8 9 10 11 more...

» German Health-Sites

Medical and health related Websites from Germany

Alternative Medicine
Beauty and Wellness
Manufacturers of Medical Equipment
German Doctors Worldwide
German Medicine and Patient Transfer
Special Diagnoses
Nutrition and Diet
Fitness and Sports
Womens Health
Health Insurance
Other Insurances
Literature and Publishers
Newspaper / Magazines
Portals and Directories
Portals and Directories Dental Medicine
Public Health
Governmental Links
North Rhine-Westphalia
Travel Medicine
Medical malpractice
Visually Impaired
Seniors / 50+
Seniors / Living
Medical Technology
Children-, Youth- and Social Work

© 2003-2008 Health Provider Directory
Clinics and Physicians
Berlin, Germany Samstag, 23.10.2021.
Sitemap (Sitemap German) Imprint Press (German)
Ärzteverzeichnis Klinikverzeichnis Apothekenverzeichnis Ärztesuche
 Thu, 21 Oct 2021 10:24:13 GMT
Werben im Gesundheitssektor / Medizin

Health Provider Directory

Medizin und Gesundheit - Arztsuche Kliniksuche Apothekensuche